Butyrolactone 3 (C007B-065256)

Catalog No.: C007B-065256
Mfr. No.: B344763-5mg
Mfr. Name: Aladdin Scientific
Qty/UOM: 1
UOM: EA

Price: $310.08

List Price: $344.53

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

Current Stock:

Quantity:

Adding to cart… The item has been added

Description
Specifications

Butyrolactone 3, also called MB-3 is an inhibitor of Histone acetyltransferase GCN5 (general control of amino-acid synthesis 5). Gcn5 HAT activity is required to acetylate histone H3 lysine 9 (K9) and K14, which allows transcription elongation by relaxing nucleosomes. Butyrolactone 3 specifically inhibits Gcn5's HAT activity. It has been shown to display anti-inflammatory and anti-carcinogenic effects. Specification: ≥95% Molecular Formula: C9H12O4 Molecular Weight: 184.19 PubChem CID: 10081070 Isomeric SMILES: CCC[C@H]1[C@@H](C(=C)C(=O)O1)C(=O)O Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/B344763-SCI_2451ba2687f4485e03693a61a65b7fb9.pdf

UPC:: 51241918
Condition:: New
Availability:: 8-12 weeks
Weight:: 0.96 Ounces
HazmatClass:: No
WeightUOM:: LB
MPN:: B344763-5mg
CAS:: 778649-18-6
Product Size:: 5mg
Hazard Statement Codes:: H319
Precautionary Statement Codes:: P264:P280:P305+P351+P338

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."